BioMarin Pharmaceutical Inc
BMRN· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $109.46M | $84.95M |
| Net Income | -$4.37M | $1.15M |
| EPS Diluted | -$0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
ended Mar 31, 2011 · filed Apr 29, 2011 · 29 d after period end